$1.85
1.07% yesterday
Nasdaq, Nov 15, 09:10 pm CET
ISIN
US00430H1023
Symbol
AXDX
Sector
Industry

Accelerate Diagnostics, Inc. Target price 2024 - Analyst rating & recommendation

Accelerate Diagnostics, Inc. Classifications & Recommendation:

Buy
50%
Hold
50%

Accelerate Diagnostics, Inc. Price Target

Target Price $1.00
Price $1.85
Deviation
Number of Estimates 1
1 Analyst has issued a Accelerate Diagnostics, Inc. price target 2025. The average Accelerate Diagnostics, Inc. target price is $1.00. This is lower than the current stock price.
A rating was issued by 2 analysts: 1 Analysts recommend Accelerate Diagnostics, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Accelerate Diagnostics, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Accelerate Diagnostics, Inc. stock at Buy or hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 12.06 11.90
5.41% 1.35%
Net Margin -1,019.54% -447.71%
31.37% 56.09%

1 Analyst has issued a sales forecast Accelerate Diagnostics, Inc. 2024 . The average Accelerate Diagnostics, Inc. sales estimate is

$11.9m
Unlock
. This is
0.11% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$11.9m 0.11%
Unlock
, the lowest is
$11.9m 0.11%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $12.1m 5.41%
2024
$11.9m 1.35%
Unlock
2025
$12.3m 3.49%
Unlock

1 Analyst has issued a net profit forecast Accelerate Diagnostics, Inc. 2024 . The average Accelerate Diagnostics, Inc. net profit estimate is

$-53.3m
Unlock
. This is
21.33% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-53.3m 21.33%
Unlock
, the lowest is
$-53.3m 21.33%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-123m 35.09%
2024
$-53.3m 56.68%
Unlock
2025
$-42.6m 20.09%
Unlock

Net Margin

2023 -1,019.54% 31.37%
2024
-447.71% 56.09%
Unlock
2025
-345.68% 22.79%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -4.94 -2.14
35.09% 56.68%
P/E negative
EV/Sales 7.09

1 Analysts have issued a Accelerate Diagnostics, Inc. forecast for earnings per share. The average Accelerate Diagnostics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-2.14
Unlock
. This is
21.32% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-2.14 21.32%
Unlock
, the lowest is
$-2.14 21.32%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-4.94 35.09%
2024
$-2.14 56.68%
Unlock
2025
$-1.71 20.09%
Unlock

P/E ratio

Current -0.68 27.66%
2024
-0.86 26.47%
Unlock
2025
-1.08 25.58%
Unlock

Based on analysts' sales estimates for 2024, the Accelerate Diagnostics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.09 13.01%
2024
7.09 0.05%
Unlock
2025
6.85 3.37%
Unlock

P/S ratio

Current 3.89 43.30%
2024
3.89 0.11%
Unlock
2025
3.76 3.38%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today